TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 49 filers reported holding TYRA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,344,143 | -18.6% | 896,452 | +0.6% | 0.00% | – |
Q2 2023 | $15,170,869 | +41.6% | 890,832 | +33.6% | 0.00% | – |
Q1 2023 | $10,716,843 | +115.3% | 666,885 | +1.8% | 0.00% | – |
Q4 2022 | $4,978,692 | -8.9% | 655,091 | +5.3% | 0.00% | – |
Q3 2022 | $5,468,000 | +21.2% | 622,098 | -1.4% | 0.00% | – |
Q2 2022 | $4,510,000 | -27.7% | 630,855 | +8.2% | 0.00% | – |
Q1 2022 | $6,242,000 | -24.6% | 583,236 | -0.9% | 0.00% | – |
Q4 2021 | $8,281,000 | – | 588,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |